-
11.
公开(公告)号:US20160038600A1
公开(公告)日:2016-02-11
申请号:US14595865
申请日:2015-01-13
Applicant: NEONC TECHNOLOGIES INC.
Inventor: Thomas Chen , Daniel Levin , Satish Pupalli
IPC: A61K47/48 , A61N5/10 , A61K45/06 , A61K31/4015 , A61K9/00
CPC classification number: A61K45/06 , A61K9/0043 , A61K31/4015 , A61K31/415 , A61K47/54 , A61K47/55 , A61N5/10 , C07D207/26 , C07D231/12 , C07D487/04
Abstract: The present invention provides for a perillyl alcohol (POH) carbamate, such as POH-Rolipram. The present invention also provides for a method of treating a disease such as cancer, by delivering to a patient a therapeutically effective amount of POH-Rolipram.
Abstract translation: 本发明提供了诸如POH-Rolipram的珀维醇(POH)氨基甲酸酯。 本发明还提供了通过向患者递送治疗有效量的POH-咯利普兰来治疗疾病如癌症的方法。
-
公开(公告)号:US20150368173A1
公开(公告)日:2015-12-24
申请号:US14817286
申请日:2015-08-04
Applicant: NEONC Technologies, Inc.
Inventor: Thomas CHEN , DANIEL LEVIN , SATISH PUPPALI
IPC: C07C29/88 , C07C201/12 , C07C67/14 , C07C201/16
CPC classification number: C07C29/92 , A61K31/045 , A61K31/4188 , A61K45/06 , A61N5/10 , C07B2200/07 , C07C29/78 , C07C29/86 , C07C29/88 , C07C67/14 , C07C201/12 , C07C201/16 , C07C2601/16 , C07C33/14 , C07C205/57 , C07C69/76 , C07C69/92
Abstract: The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.
Abstract translation: 本发明提供纯化大于约98.5%(w / w)的单萜或倍半萜的方法。 该方法包括衍生单萜(或倍半萜烯)以产生单萜(或倍半萜烯)衍生物,分离单萜(或倍半萜烯)衍生物和从衍生物中释放单萜(或倍半萜烯)的步骤。 包括本发明范围的药物组合物是包含纯度大于约98.5%(w / w)的单萜(或倍半萜烯)的药物组合物。 纯化的单萜可用于治疗癌症等疾病。 本单萜(或倍半萜烯)可以单独施用,或者可以与辐射或其它治疗剂如化学治疗剂共同施用。
-
公开(公告)号:US20150359754A1
公开(公告)日:2015-12-17
申请号:US14833210
申请日:2015-08-24
Applicant: NEONC TECHNOLOGIES INC.
Inventor: Thomas CHEN , Daniel Levin , Satish Pupalli , Daniel Anthony Dickman
IPC: A61K31/045 , A61N5/10 , A61K47/48 , A61K45/06 , A61K31/325
CPC classification number: A61K31/045 , A61K31/05 , A61K31/165 , A61K31/325 , A61K31/4015 , A61K31/415 , A61K31/4188 , A61K45/06 , A61K47/54 , A61K47/55 , A61N5/10 , C07B2200/07 , C07C271/22 , C07D207/26 , C07D231/12 , C07D487/04 , A61K2300/00
Abstract: The present invention provides for a method of treating a disease such as cancer, comprising the step of administering to a patient a therapeutically effective amount of an isomer or analog of monoterpene or sesquiterpene (or its derivative), such as an isoperillyl alcohol. The present invention also provides for a method of treating a disease comprising the step of administering to a patient a therapeutically effective amount of a derivative of an isomer or analog of monoterpene or sesquiterpene, such as an isoperillyl alcohol carbamate. The derivative may be an isoperillyl alcohol conjugated with a therapeutic agent such as a chemotherapeutic agent. The route of administration may vary, including inhalation, intranasal, oral, transdermal, intravenous, subcutaneous or intramuscular injection.
Abstract translation: 本发明提供了治疗诸如癌症的疾病的方法,包括向患者施用治疗有效量的单萜烯或倍半萜烯(或其衍生物)的异构体或类似物,例如异环戊醇。 本发明还提供了治疗疾病的方法,其包括向患者施用治疗有效量的单萜或倍半萜的异构体或类似物的衍生物,例如异哌环醇氨基甲酸酯的步骤。 衍生物可以是与治疗剂如化学治疗剂缀合的异环戊醇。 给药途径可以变化,包括吸入,鼻内,口服,透皮,静脉内,皮下或肌内注射。
-
14.
公开(公告)号:US20140364472A1
公开(公告)日:2014-12-11
申请号:US14455371
申请日:2014-08-08
Applicant: NEONC TECHNOLOGIES INC.
Inventor: Thomas Chen , Daniel Levin , Satish Pupalli
IPC: A61K47/48 , A61K31/495 , A61N5/10 , A61K45/06
CPC classification number: C07C33/14 , A61K9/0043 , A61K31/045 , A61K31/4015 , A61K31/415 , A61K31/4188 , A61K31/495 , A61K45/06 , A61K47/54 , A61K47/542 , A61K47/543 , A61N5/10 , C07B59/00 , C07B2200/05 , C07C2601/16 , C07D207/26 , C07D231/12 , C07D487/04
Abstract: The present invention provides for a derivative of monoterpene or sesquiterpene, such as a perillyl alcohol derivative. For example, the perillyl alcohol derivative may be a perillyl alcohol carbamate. The perillyl alcohol derivative may be perillyl alcohol conjugated with a therapeutic agent such as a chemotherapeutic agent. The present invention also provides for a method of treating a disease such as cancer, comprising the step of delivering to a patient a therapeutically effective amount of a derivative of monoterpene (or sesquiterpene). The route of administration may vary, and can include, inhalation, intranasal, oral, transdermal, intravenous, subcutaneous or intramuscular injection.
Abstract translation: 本发明提供单萜或倍半萜衍生物,例如芳香醇衍生物。 例如,紫苏醇衍生物可以是芳族醇氨基甲酸酯。 紫苏醇衍生物可以是与治疗剂如化学治疗剂缀合的紫苏醇。 本发明还提供了治疗诸如癌症的疾病的方法,其包括向患者递送治疗有效量的单萜(或倍半萜烯)衍生物的步骤。 给药途径可以变化,并且可以包括吸入,鼻内,口服,透皮,静脉内,皮下或肌内注射。
-
公开(公告)号:US12208066B2
公开(公告)日:2025-01-28
申请号:US18190416
申请日:2023-03-27
Applicant: NeOnc Technologies, Inc.
Inventor: Thomas Chen
IPC: A61K31/045 , A61K9/00 , A61K31/4015 , A61K31/415 , A61K31/4188 , A61K31/4745 , A61K35/17 , A61K39/00 , A61K39/395 , A61K45/06 , A61P35/00 , C07K14/705 , C07K16/28 , C07K16/42 , C12N5/0783 , C12N5/16 , C12P5/00
Abstract: The present invention relates to using monoterpene or sesquiterpene to permeabilize the blood brain barrier.
-
公开(公告)号:US11970436B2
公开(公告)日:2024-04-30
申请号:US17749293
申请日:2022-05-20
Applicant: NEONC Technologies, Inc.
Inventor: Thomas Chen , Daniel Levin , Satish Puppali
IPC: C07C29/92 , A61K31/045 , A61K31/4188 , A61K45/06 , A61N5/10 , C07C29/78 , C07C29/86 , C07C29/88 , C07C67/14 , C07C201/12 , C07C201/16
CPC classification number: C07C29/92 , A61K31/045 , A61K31/4188 , A61K45/06 , A61N5/10 , C07C29/78 , C07C29/86 , C07C29/88 , C07C67/14 , C07C201/12 , C07C201/16 , C07B2200/07 , C07C2601/16 , C07C29/92 , C07C33/14 , C07C201/12 , C07C205/57 , C07C67/14 , C07C69/76 , C07C67/14 , C07C69/92
Abstract: The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.
-
公开(公告)号:US20230233481A1
公开(公告)日:2023-07-27
申请号:US18190416
申请日:2023-03-27
Applicant: NeOnc Technologies, Inc.
Inventor: Thomas CHEN
IPC: A61K31/045 , A61P35/00 , A61K9/00 , A61K31/4015 , A61K31/415 , A61K31/4188 , A61K31/4745 , A61K35/17 , A61K39/395 , A61K45/06 , C07K14/705 , C07K16/42
CPC classification number: A61K31/045 , A61P35/00 , A61K9/0019 , A61K9/0043 , A61K9/0078 , A61K31/4015 , A61K31/415 , A61K31/4188 , A61K31/4745 , A61K35/17 , A61K39/3955 , A61K45/06 , C07K14/70503 , C07K16/42 , A61K2039/505
Abstract: The present invention relates to using monoterpene or sesquiterpene to permeabilize the blood brain barrier.
-
公开(公告)号:US20230145207A1
公开(公告)日:2023-05-11
申请号:US18150933
申请日:2023-01-06
Applicant: NEONC TECHNOLOGIES, INC.
Inventor: Thomas CHEN , Daniel LEVIN , Satish PUPPALI
IPC: A61K31/20 , A61K47/55 , A61K9/00 , A61K31/045 , A61K45/06
CPC classification number: A61K31/20 , A61K47/55 , A61K9/0043 , A61K31/045 , A61K45/06
Abstract: The present invention provides for a method of treating a disease such as cancer, comprising the step of administering to a patient a therapeutically effective amount of a perillyl alcohol derivative such as a perillyl alcohol ester, or an isoperillyl alcohol derivative such as an isoperillyl alcohol ester. The derivative may be a perillyl alcohol or an isoperillyl alcohol conjugated with a therapeutic agent such as valproic acid. The route of administration may vary, including inhalation, intranasal, oral, transdermal, intravenous, subcutaneous or intramuscular injection.
-
公开(公告)号:US20230043663A1
公开(公告)日:2023-02-09
申请号:US17943567
申请日:2022-09-13
Applicant: NeOnc Technologies, Inc.
Inventor: Thomas CHEN , Daniel LEVIN , Satish Puppali
IPC: C07D487/04 , C07D231/12 , A61P35/00
Abstract: A pharmaceutical composition is provided which includes perillyl alcohol conjugated with a therapeutic agent and further includes and a hydrolyzable acylated aliphatic tail. A method of using the pharmaceutical composition is also provided for treating a condition or disease of a patient, e.g., cancer.
-
公开(公告)号:US20220054481A1
公开(公告)日:2022-02-24
申请号:US17503760
申请日:2021-10-18
Applicant: NeOnc Technologies, Inc.
Inventor: Thomas CHEN
IPC: A61K31/495 , C07D231/12 , A61K31/4188 , A61K47/54 , C07B59/00 , A61K31/4015 , A61K9/00 , A61K31/045 , A61K31/415 , C07D207/26 , C07C33/14 , C07D487/04 , A61K45/06 , A61N5/10 , A61K31/635 , A61K47/55 , A61K31/366
Abstract: The present methods treat neurofibromatosis by a administering to a subject perillyl alcohol or iso-perillyl alcohol. The present methods also treat neurofibromatosis by administering to a subject a carbamate of perillyl alcohol, or a carbamate of iso-perillyl alcohol. The perillyl alcohol carbamate may comprise perillyl alcohol conjugated with rolipram or temozolomide.
-
-
-
-
-
-
-
-
-